chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme pain, swelling and stiffness.  Unable to move right arm after given Pneumovax vaccine. Felt as though "something was biting her" and might have hit a nerve. Went to her physician and was given a prescription for Percocet. Advised to ice the area and take ibuprofen 600 mg every 6 hours to help with swelling and inflammation.
suicidal thoughts; muscles were cramping; constipated; physical and emotional breakdown; physical and emotional breakdown; vomiting; excruciating pain specially on her left side, from left shoulder to her neck and up into the skull; This is a spontaneous report received from a contactable consumer (patient's mother). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced suicidal thoughts on an unspecified date, muscles were cramping on an unspecified date, constipated on an unspecified date, physical and emotional breakdown on an unspecified date, vomiting on an unspecified date, excruciating pain on an unspecified date. The consumer (patient's mother) had a violent reaction a week after the covid vaccine; all her muscles were cramping, and she ended up in a wheelchair. She was also constipated and had to take a laxative, she had a physical and emotional breakdown, vomiting, excruciating pain specially on her left side, from left shoulder to her neck and up into the skull, and suicidal thoughts. She went to ER with her husband. Son (patient) got the shot and had the same events as her. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Per patient: "Couple of hours after vaccine" became disoriented, delusional, lost track of time, did not recognize others; don't remember much until woke up next morning."
I was tired that I could not even lift arms or legs which happened suddenly. Then I had a fever. My heartrate was elevated to in the 100s and this lasted for one month. I had chills and body aches with a headache for 9-10 days. Tylenol did not help. I could not concentrate on my work. I went to my doctor because I had swollen glands under my chin on both sides. My arm also hurt for weeks. My doctor stated that it was due to my vaccine. I still had the swollen glands until the next vaccine.
prior to staring kindergarten 2wks post vax t105-106 strange look in eyes-marks in mouth;dx measles;pt writes name backwards
My first dose of this vaccine was 5/25/2018 - after this dose I had about 3 days of low fever and aches -my fever did not go over 100. I took 500 mg doses of Tylenol to reduce the fever. After this injectioon, I looked for information on what to expect for the second dose based on the symptoms of the first dose - I was considering not completing the the vaccine. I did not find information that I thought was helpful. I got the second dose on 9/14 - the symptoms appeared more quickly and were more intense after the second dose - it stated with chills and then a temperature of 101 for a few hours - which I broke with Tylenol (500 mg) and cold compresses. Thankfully the fever is gone after the third day, but I still  have a very sore arm and am tired. I did not find the directions with the vaccine helpful:  "Only with your provider's okay try acetaminophen or ibuprofen as needed for pain or fever."  How do you get the provider's permission to try acetaminophen when the fever occurs in the middle of the night?  It would be more appropriate to state the dose that should be used for help with fever.
At approximately 24 hours after his vaccine, Pt started to have problems with his vison and headache on the right side.  It took 2 calls to 911 before I could convince him to go the the ER. While there, he suffered 2 grand mal seizures and he was transferred to another hospital for further treatment.
Jan. 19, 2022, I got Covid illness. My tinnitus ringing increased very much. Not sure if the Covid vaccines caused it or not. I have had all the 3 shots (booster). I will see an ENT doctor next week to tell more about this issue.
This case was reported by a physician and described the occurrence of vasovagal response in a 15-year-old female subject who was vaccinated with TWINRIX (GlaxoSmithKline). Previous and/or concurrent vaccination included BOOSTRIX; GlaxoSmithKline given on 25 June 2009. On 25 June 2009 at 16:40 the subject received 1st dose of TWINRIX (1 ml, unknown, left arm). On 25 June 2009, immediately after vaccination with TWINRIX, the subject experienced vasovagal response, fainting and inadvertent exposure to vaccine. The 15-year-old subject inadvertently received TWINRIX. Additionally, the subject had a vasovagal response immediately after receiving TWINRIX and then fainted. The office subsequently checked the subject blood sugar and blood count, which were both normal. This case was assessed as medically serious by GSK. At the time of reporting the vasovagal response had resolved, the outcome of the fainting was unspecified.
Received Dtap and MMR on 7/30. Mother called on 7/31 at 8:30 am to report to child awoke with "hives" on extremities. Spoke to dr-told to give BENADRYL and report back if no change or worse.
Information has been received from a physician concerning a patient of unknown age and gender. The patient's medical history and current conditions were not reported. On 30-APR-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) (dose, frequency, route of administration, lot# and expiration date were not reproted). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient called in with symptoms of arm swelling and muscle pain. Pt stated she could barely move her arm up and down for a few days. Pt received vaccine on 4/6/18 and called in on 4/9/18 to report symptoms and at that time had stated her arm was doing better that day. Pt started taking Ibuprofen for the pain before calling in on 4/9/18. Orders to continue the Ibuprofen as needed, ice/heat to arm as needed and gentle ROM.
Painful, swollen lymph node under the jaw, left side Painful lymph node near armpit, left side Extreme fatigue
No adverse etfects reported; patient received improperly stored dose of MMR II; This spontaneous report was received from a nurse and refers to a 18-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 16-JUL-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R024905, expiration date 30-AUG-2020, albumin status rHA (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of above 47 degrees Fahrenheit (54 degrees Fahrenheit) for 17 hours and 15 minutes on 12-JUL-2019. Data logger was involved. There were no previous excursions reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1911USA004662:
This spontaneous report has been received from the patient's mother referring to a 12 years old female patient. The patient had no pertinent medical history, drug allergies/reactions, or concomitant therapies.  On 30-DEC-2016, the patient was vaccinated with the third dose of GARDASIL 9 regimen (previous vaccination information was not provided) for the prevention of human papillomavirus (lot #, expiration date, dose, and anatomical location were not reported). It was reported by the patient's mother that on the same day the patient fainted briefly after receiving the vaccination with GARDASIL 9 (syncope) and fell. She reported also that the patient recovered immediately after the event, and had no lasting effects from the fall. The patient was feeling well enough afterward to receive a "flu-shot" (manufacturer or strength not reported). In addition, the patient's mother reported that the nurse practitioner stated that the event could have occurred as a result of the patient's blood pressure dropping rapidly post injection  (Blood pressure decreased) and that they have had similar occurrences of fainting with other unspecified patients. The patient did not receive treatment, had lab diagnosis studies performed or sought medical attention for these events. No product quality complaint was involved. The causality assessment between the events and the suspect product was not reported. This is one of several reports received from the same reporter Additional information has been requested.
Information has been received from a registered nurse concerning a female with a history of leukaemia in 1995 and no drug allergies, who on 29-JUN-1998 and 23-AUG-2007 was vaccinated with her first and second 0.5ml SC dose of varicella virus vaccine live (Oka/Merck) (Lot number unknown for both doses). Concomitant therapy included fexofenadine hydrochloride (ALLEGRA). The patient failed to seroconvert following the administration of her first dose of varicella virus vaccine live (Oka/Merck). Unspecified medical attention was sought. Lab diagnostic studies included a seronegative VZV antibody titer. The patient's recovery status was unknown. There was no product quality complaint. Additional information has been requested.
Sore arm still present after 48 hours. Mild skin rash at injection site still present after 48 hours. Very mild flu-like symptoms onset after 24 hours diminishing after 36 hours.
Information has been received from a consumer concerning a 24 month old male pt, with no known drug allergies, who was vaccinated IM with a dose of MMR II. There were no concomitant medications. The reporter indicated that the pt was being treated for failure to thrive. It was reported that the nurse administering the vaccine stated that "it was alright to administer it IM and that others in the office were doing the same thing. Unspecified medical attention was sought. Upon internal review, failure to thrive was considered to be an important medical event (OMIC). Additional info has been requested. The reporter indicated that another pt had a similar experience (WAES0303USA01675).
3 Seizures, 1 at home 2 at hospital lasted about 1 min. DC DX: Seizures without any apparent cause, two episodes, seizure free for the last 24 hours. In ER observed generalized tonic, clonic seizure lasting less than one minutes and resolved on its own without any medication. At the time of the immunizations 2 days prior, had diarrhea 3-5 bowel movements everyday, mostly watery and runny. No blood in the bowel movements. No vomiting. No fever. Temp 99.3.  PE: unremarkable. Neurolgoic: at time of exam patient was in post-ictal state and his tone was normal all over the body.
we have had 3 doses total; This case was reported by a consumer via interactive digital media and described the occurrence of extra dose administered in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first 2 doses on unknown date).   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional information was provided as follows:  The age at vaccination was not provided. The age group was not reported but was captured as adult as per vaccine indication. The patient received 3 doses of Shingrix, which led to extra dose administered. The reporter stated that, after getting shingrix vaccine, The reporter found paperwork which showed that the patient had already received 2 doses. The reporter asked for the risk of having 3 doses of Shingrix. This case has been linked with US2021AMR101279, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR101279:same reporter
FIBRILLATION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age, sex and ethnic origin The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) 1 total, dose and start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced fibrillation, for which the patient had heart shocked 3 times, but it only helped for a short while. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fibrillation was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20230906188- Fibrillation. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.
PRINZMETAL ANGINA ACUTE ST ELEVATION MI, ANTERIOR WALL ACUTE ST ELEVATION MI, UNSPECIFIED 3/19/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
PT. HAD FLUSHOT 12/15/08 AND MOTHER SPOKE WITH ON CALL PHYSICIAN 12/16/08 AND STATED SHORTLY AFTER FLUSHOT PATIENT UNABLE TO CLOSE RIGHT EYE, DROOPY MOUTH ON RIGHT, SLIGHT RIGHT EAR PAIN.  PT SEEN AT HOSPITAL THAT EVENING AND DIAGNOSED WITH BELLS PALSY. PATIENT PRESCRIBED PREDNISONE 60 MG 1 PO Q DAY AND VALTREX 1 GM 1 PO TID BY ER AND FOLLOWED UP ON 12/19/08.  ONLY OTHER TREATMENT ADDED WAS METHYLCELLULOSE OINTMENT TO KEEP EYE MOIST.
Information has been received from a physician concerning a female (demographics not reported) who on an unspecified date was vaccinated with Gardasil (yeast) (Lot# not provided). Subsequently the patient developed hives. At the time of this report it was unknown if the patient had recovered from the hives. Additional information has been requested. This is in follow-up to report(s) previously submitted on 2/14/2007. Follow up information received stated that the patient developed hives after receiving the second dose of GARDASIL (Lot # not provided) on an unspecified date in approximately January, 2007. The patient was treated in the physicians office with a dose of an unspecified antihistamine. At the time of this report it was not reported if the patient had recovered from the event. Additional information has been requested.
Received injection approx 4pm - woke @ midnite with R arm shooting pain - pain intermittent for several days - saw PCP (said "inappropriate admin, injection as dx) -given Rx - MEDROL pack - x 6 days. - no relief - again saw PCP - will schedule MRI if persists - definitely nerve and maybe small. may heal on its own"
Case number PHEH2012US014501 is an initial spontaneous report received from a nurse on 18 Jul 2012. This case refers to a 19-year-old breastfeeding female patient. She was vaccinated with MENVEO (batch number: A10065) intramuscularly on 18 Jul 2012. No other information was available at the time of this report.
It?s been a week since my second vaccine and I am still feeling very tired and I?m having trouble sleeping
Headache, Myalgia, Then he had lower right body soreness, then 12/29 myalgias and chills; all resolved on day 3 except for headache.
COVID-19 Vaccine   Vaccine Lot Number:  025B21A  first dose 11:50am onset: no dif breathing, no tightness redness on left arm. no aniplaphic reactions. Pt had flush left arm. the reaction started 5-10 mins after her vaccine. The flushness went away 5-10mins after it started. she did not have any edema or raised hives. She denied all other symptoms including respiratory symptoms. Pt was monitored and she signed a pt refusal for further treatment or transport. pt was advised to seek medical attention if the flushness came back or if she developed any other symptoms. 12:00 140/86 p79 r16 pox 98%; 12:16 157/96 p76 r 16 POX 97%
a couple of years ago he received Shingrix shot 1 but he never got shot number 2; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix a couple of years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: a couple of years ago he received Shingrix shot 1 but he never got shot number 2). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 08-JUN-2023 The reporter was the patient.  The patient did not want to give his date of birth. The patient never got shot number 2 of Shingrix. The reporter did not get a chance to ask for MD contact.  It was difficult to communicate with this customer over the phone.  He was fine with safety sending him a letter. The reporter provided limited information. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
On 1/4 2021, 7 days post injection she devloped a 4x6 mildly pruritic erythematous rash at the vaccination site. It is slowly fading
Pt was here for her first monovalent Pfizer in the initial (primary) series; however, pt was given a bivalent booster for her first vaccination. Per CDC she would not need to repeat the first with a monovalent on the same day. So we advised pt to return in 21 days for her next vaccination as a monovalent for #2 and a bivalent booster after that. Pt stayed for 15 min after vaccination without signs or symptoms and went home without incident or adverse reaction.
On December 26, 2022, I had a fever of 104-degrees. I had a fever on and off for a few weeks after that averaged 101-degrees. I was tested for COVID-19 and Flu. Both tests came back negative. The illness lasted for about a month. It included severe sinus pain, a lot of jaw and tooth pain, significant nasal congestion, and a horrible cough. I was also very fatigued. I treated it with TYLENOL and MUCINEX. I saw my doctor. She prescribed doxycycline. That was almost two weeks after my symptoms started. The fevers ended, but the other symptoms lasted for about a month. On February 6, 2023, I contracted COVID-19. I called the doctor. I was offered PAXLOVID, but I decided not to take it. They symptoms resolved in about a week.
The patient was supposed to receive the Moderna Bival Booster but instead received the Fluzone HD. The patient is aware and no reactions occurred.
Dispensed 28 doses of expired Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dispensed 28 doses of expired Moderna Covid-19 vaccine) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dispensed 28 doses of expired Moderna Covid-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dispensed 28 doses of expired Moderna Covid-19 vaccine) outcome was unknown. Not Provided  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were taken by the patient. The vial did not undergo any temperature excursion and it was unknown when the vial initially stored in the refrigerator.  It was reported that patient did not experienced any adverse events from the vaccine on 08-Apr-2022.   Total number of vials/doses was 28 Treatment medications were not reported.
Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (can't taste anything after covid shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (can't taste anything after covid shot). At the time of the report, AGEUSIA (can't taste anything after covid shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not provided. Treatment information was not provided.
Left upper outer arm red with irregular shape on outer upper arm hot to touch, itches. No SOB, No rash.
Breakthrough COVID . First vaccine 2/1/21. Patiet not boostered. Pt is an 84 yo M admitted on 1/12/22 for syncopal episodes and weakness. He also endorsed cough with productive sputum although pt has hx. of pulm fibrosis and said this was normal. ED workup included EKG showing sinus tach w/PVC's, hyponatremia, Chest XR showed mild to moderate bibasilar multifocular reticular opacities likely representing chronic bronchiolisit. He was given IVF and was admitted for cardiac workup. Pt. had + COVID test on 1/20/22 after being screened for SNF placement.
This spontaneous report was received from a pharmacist refers to approximately 7 patients of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. It was reported that, temperature excursion was occurred for ZOSTAVAX in April at a temperature of 21F for 11 hours and 30 minutes. On unspecified dates, approximately 7 patients were vaccinated with improperly stored ZOSTAVAX of dose 0.65 ml, lot # L044529, expiry date 09-FEB-2017, subcutaneously (dose number, strength, vaccination site not provided) since temperature excursion. No adverse events were reported by patients. On 20-JUN-2016 (reported as "last night"), temperature excursion was occurred again at temperature of 6.8F for 11 hours and 30 minutes. The vaccine was not administered to the patients since 20-JUN-2016 (reported as "last night excursion"). Product quality complaint (PQC) was not involved. Additional information has been requested.
Moderna vaccine was administered to this patient, who is 16 years old . WICHD Doctor was notified. State was notified. Patient did not have any adverse effects.
Patient received moderna vaccine on 3/18/21, 4/15/21, and 12/14/21. COVID positive on 3/26/22. Presented to ER on 3/26/22. presented to the emergency department on the date of admission with worsening respiratory issues and mental status changes.  He was found significantly hypotensive, leucocytosis, AMS changes, aphasic, etc .  Was given copious fluid boluses and admitted to the ICU on Levophed.  Initially was unresponsive but after fluids became more responsive.  Was tested and found positive for COVID.  Had UTI complicated by chronic Foley.  Significant labs included leukocytosis, lactic acidosis and had an acute kidney injury.  Was started on broad-spectrum antibiotics, vancomycin and Zosyn.  Was given remdesivir and Decadron.  Oxygen provided per protocol.  Had significant improvement over the 1st 24 hours in terms of mental status and was at baseline the day after admission.  Was eating.  Blood pressure had improved and was stable. By 03/29/2022 he was no longer requiring supplemental oxygen.  Generally appeared to be his baseline.  He was stable for discharge and was discharged to home on 03/30/2022.
1) Right thigh at DTaP inj site 3in x 2in oblong knot/swelling red, sore, warm to touch. 2) Rx Benadryl, cold compression, Tylenol F/U on Friday.